Sequana Medical Investor Presentation 2024 - Fluid Overload Treatment

Loading viewer...

investor_presentation

Format: PDF investor_presentation

Sequana Medical presents its innovations in treating fluid overload across liver disease, heart failure, and cancer. The company develops the alfapump® system for refractory ascites and DSR® therapy, with regulatory approvals in Europe and ongoing clinical investigations in the US and Canada.

Browse all investor_presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Sequana Medical

View all →

Sequana Medical 2021 BioCapital Europe Presentation

investor_presentation

19 Pages

Sequana Medical 2021 H.C. Wainwright Global Investment Conference

conference

Similar investor_presentations from other companies

Browse all →

Peraso (PRSO) mmWave Technology Investor Presentation 2024

investor_presentation

31 Pages

Peraso Inc.

Kimball Electronics Investor Presentation — February 2022

investor_presentation